Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 3Plasma cell 2NET 1Endocrine 1

Conditions

Neuroendocrine Tumors 28Neoplasms 4Melanoma 4Carcinoma, Neuroendocrine 4Sarcoma 3Pheochromocytoma 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Liver Neoplasms 3Gastro-enteropancreatic neuroendocrine tumor 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma 3Carcinoid Tumor 3Breast Neoplasms 3Thyroid Neoplasms 2Thymus Neoplasms 2Stomach Neoplasms 2Salivary Gland Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Paraganglioma 2Neoplasms by Site 2Neoplasms by Histologic Type 2Neoplasm Metastasis 2Multiple Myeloma 2Meningioma 2Lung Neoplasms 2Insulinoma 2Head and Neck Neoplasms 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fibrosarcoma × NET × 30 days × Clear all
NCT06881992 2026-05-18

Tumor HI

Rezolute

Phase 3 Recruiting
16 enrolled
EndocrineNETSarcoma

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡